Horsham, UK. June 25th, 2018. Technology-led CRO Cmed have today launched a brand new website dedicated to allowing visitors to explore the benefits and advantages that encapsia® brings to delivering clinical trials at http://www.encapsia.com.
The homepage details how encapsia® streamlines the capture, management and reporting of clinical data beyond what is currently possible. Designed as a single platform with a single data repository and an app based architecture, it manages all clinical data types and offers live access to all clinical data, from whatever source. It solves the problems caused by having overlapping, siloed systems with poor interoperability and clinical data fragmented in many different systems. Through its sophisticated analytics capabilities, encapsia® provides not only live graphical insights that can have issues identified and actioned WITHIN the system, but also immediate access to the latest analytics tools able to run sophisticated algorithms. These include algorithms derived from the use of Artificial Intelligence, allowing immediate interpretation of a variety of digital health measurements such as from wearable sensors, images etc. This offers sponsors the benefits of running faster, more efficient clinical trials and making better, quicker, informed decisions.
The website, encapsia.com was built to provide quick and easy access to essential information and features that enable an easy and more comprehensive understanding of how encapsia® improves the conduct of clinical trials. The website includes videos which demonstrate some of the unique benefits the modern, app based architecture of encapsia® delivers compared to today’s conventional platforms.
The website has sections dedicated to the main apps within the clinical data suite like eSource, EDC, Insights or Conduct.
“We are really excited about the launch of encapsia.com and have built the site to allow easy access to the product benefits encapsia® has for our customers, partners and media” says Dr. David Connelly, Cmed CEO.
The site launch date was selected to coincide with the DIA Annual Meeting 2018 in Boston. For more information on Cmed and encapsia®, and to explore the new website go to www.encapsia.com.
About Cmed
Cmed is a technology-led CRO that specializes in oncology, immuno-oncology, cell therapy and other specialty therapeutics. Our experienced industry professionals provide full CRO services, functional data management and analysis, and have developed a new generation data capture, management and analytics technology, providing live analytics and more efficient clinical trials.
Media contacts:
Sally Vernon, Marketing Director, sally@rockpigeon.co
Claudia Cernea, Marketing Specialist, ccernea@cmedgroup.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.